ComparisonBiomarkers

IBS vs IBD

Two very different diseases with confusingly similar names

Irritable Bowel SyndromeA disorder of gut–brain interaction

Inflammatory Bowel DiseaseImmune-mediated bowel inflammation

Last reviewed: July 2026
Version: 1.0
Review cadence: Annually

At a Glance

The 30-second view

Tissue damage
Irritable Bowel Syndrome
None — the bowel is structurally normal
Inflammatory Bowel Disease
Yes — visible, measurable inflammation
Faecal calprotectin
Irritable Bowel Syndrome
Normal
Inflammatory Bowel Disease
Raised
The problem
Irritable Bowel Syndrome
Dysregulated gut–brain signalling
Inflammatory Bowel Disease
Immune system attacking the bowel
Treatment
Irritable Bowel Syndrome
Diet, fibre, gut-directed behavioural therapy
Inflammatory Bowel Disease
Biologics and immunosuppression — medical therapy
Consequences if untreated
Irritable Bowel Syndrome
Symptoms and reduced quality of life
Inflammatory Bowel Disease
Bowel damage, surgery, cancer risk

Dimension	Irritable Bowel Syndrome	Inflammatory Bowel Disease
Tissue damage	None — the bowel is structurally normal	Yes — visible, measurable inflammation
Faecal calprotectin	Normal	Raised
The problem	Dysregulated gut–brain signalling	Immune system attacking the bowel
Treatment	Diet, fibre, gut-directed behavioural therapy	Biologics and immunosuppression — medical therapy
Consequences if untreated	Symptoms and reduced quality of life	Bowel damage, surgery, cancer risk

Overview

IBS and IBD sound almost identical and can produce overlapping symptoms, but they are fundamentally different conditions with entirely different treatments and stakes. Confusing them is one of the more consequential mix-ups in gastroenterology — and one patients make constantly, understandably, because of the names.

Quick summary

IBS is a disorder of gut–brain signalling: real, common, sometimes disabling, but it causes no tissue damage and does not lead to cancer or surgery. IBD is immune-mediated inflammation that physically damages the bowel and, untreated, can lead to hospitalisation, surgery, and increased colorectal cancer risk. Faecal calprotectin is the test that separates them — normal in IBS, raised in IBD. The distinction determines whether treatment is dietary and behavioural, or medical and urgent.

When each is appropriate

Choose Irritable Bowel Syndrome

Symptoms without alarm features, with a normal calprotectin — a positive diagnosis, not a dismissal.

Choose Inflammatory Bowel Disease

Raised calprotectin, bleeding, weight loss, anaemia, or nocturnal symptoms — this needs endoscopy and medical care, not supplements.

Evidence comparison

Inflammation present
Irritable Bowel Syndrome
No
Inflammatory Bowel Disease
Yes
Faecal calprotectin
Irritable Bowel Syndrome
Normal
Inflammatory Bowel Disease
Raised
Endoscopy findings
Irritable Bowel Syndrome
Normal bowel
Inflammatory Bowel Disease
Ulceration and inflammation on biopsy
Blood in stool
Irritable Bowel Syndrome
Not typical — always investigate
Inflammatory Bowel Disease
Common, especially in colitis
Weight loss / anaemia
Irritable Bowel Syndrome
Not typical — always investigate
Inflammatory Bowel Disease
Common
Colorectal cancer risk
Irritable Bowel Syndrome
Not increased
Inflammatory Bowel Disease
Increased — surveillance required
Effective treatment
Irritable Bowel Syndrome
Fibre, low-FODMAP, CBT/hypnotherapy
Inflammatory Bowel Disease
Biologics, immunomodulators, 5-ASA

Dimension	Irritable Bowel Syndrome	Inflammatory Bowel Disease
Inflammation present	No	Yes
Faecal calprotectin	Normal	Raised
Endoscopy findings	Normal bowel	Ulceration and inflammation on biopsy
Blood in stool	Not typical — always investigate	Common, especially in colitis
Weight loss / anaemia	Not typical — always investigate	Common
Colorectal cancer risk	Not increased	Increased — surveillance required
Effective treatment	Fibre, low-FODMAP, CBT/hypnotherapy	Biologics, immunomodulators, 5-ASA

Safety comparison

Risk of getting it wrong
Irritable Bowel Syndrome
Being told you have IBS when you have IBD delays treatment and risks permanent bowel damage
Inflammatory Bowel Disease
Being told you have IBD when you have IBS risks unnecessary immunosuppression

Dimension	Irritable Bowel Syndrome	Inflammatory Bowel Disease
Risk of getting it wrong	Being told you have IBS when you have IBD delays treatment and risks permanent bowel damage	Being told you have IBD when you have IBS risks unnecessary immunosuppression

Strengths & limitations

Irritable Bowel Syndrome

A positive diagnosis with genuinely effective dietary and behavioural treatments

Does not damage the bowel or raise cancer risk

Frequently dismissed as 'nothing wrong', which is both wrong and harmful

No single confirmatory test — it is a positive clinical diagnosis

Inflammatory Bowel Disease

Highly treatable with modern biologic therapy

Objectively measurable — calprotectin and endoscopy make it verifiable

Requires lifelong medical management and monitoring

Carries risk of surgery and increased colorectal cancer risk

Frequently asked questions

My symptoms feel severe — doesn't that mean it's IBD?

No. Symptom severity does not distinguish the two: IBS can be severe and disabling while causing no tissue damage at all, and IBD can be relatively mild symptomatically while quietly inflaming the bowel. That is exactly why an objective test — faecal calprotectin — matters more than how bad it feels.

Can IBS turn into IBD?

No. They are different diseases, and one does not become the other. A person can have both, and IBS-type symptoms are common in people whose IBD is in remission — which is a real and often frustrating clinical situation, but it is not IBS transforming into IBD.

Which symptoms mean I should see a doctor urgently?

Blood in the stool, unintentional weight loss, anaemia, symptoms that wake you at night, or a family history of bowel cancer or IBD. These alarm features are not typical of IBS and warrant proper investigation rather than self-management.

Continue Exploring

Where to go next

References & sources

NICE diagnostics guidance on faecal calprotectin
ACG Clinical Guidelines: IBS; Ulcerative Colitis; Crohn's Disease
Rome IV criteria

Comparisons synthesize BioSignal's existing calibrated evidence — they introduce no new conclusions. Figures and verdicts trace to the linked Signal Records and Foundations.

Educational information — not medical advice

Comparisons orient a decision; they don't make it for you. Choices between medications, supplements, or programs belong with a qualified clinician. See our Medical Disclaimer.

Is this comparison clear, balanced, and useful? Your feedback shapes what we review next.

Give feedback